Trump admin HHS moves to curb ‘overmedicalization’ on antidepressants
The Trump administration's Health and Human Services Department, under Secretary Robert F. Kennedy Jr., is taking steps to reduce the overuse of antidepressants and psychotropic medications, particularly among children and young adults. The initiative, part of the Make America Healthy Again agenda, emphasizes education, outreach, and policy changes to address what officials describe as overmedicalization. While affirming that medications have a role, officials stress the importance of understanding risks and exploring holistic alternatives like therapy, exercise, and nutrition.
- ▪HHS Secretary Robert F. Kennedy Jr. announced a multipronged approach to curb overprescription of SSRIs and other psychotropic drugs.
- ▪Roughly 11% of U.S. adults and nearly 4% of those 17 and younger had an SSRI prescription as of 2024.
- ▪The American Academy of Pediatrics found antidepressant dispensing rates for ages 12 to 25 increased over 66% from 2016 to 2022.
- ▪SSRIs carry rare but serious side effects, including increased suicidal ideation in those under 25 and post-SSRI sexual dysfunction.
- ▪Assistant Secretary for Health Admiral Brian Christine advocates for holistic mental health approaches, including relationships, diet, and exercise.
Opening excerpt (first ~120 words) tap to expand
Senior Trump administration Health and Human Services officials are laying the groundwork to halt the rapid rise in recent years in prescriptions of antidepressants and other mental health medications as part of the Make America Healthy Again agenda. HHS Secretary Robert F. Kennedy Jr. announced during an event at the MAHA Institute on Monday that his department would begin taking steps to curb what he described as the overmedicalization of mental health conditions and the over-prescription of psychotropic medications.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
